Manchester Financial Inc Tandem Diabetes Care Inc Transaction History

Manchester Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$77.0 - $100.19 $19,250 - $25,047	-250 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$81.28 - $104.34 $9,834 - $12,625	-121 Reduced 32.61%	250 $22,000
Q4 2020 Jan 26, 2021	BUY	$86.4 - $121.75 $10,454 - $14,731	121 Added 48.4%	371 $35,000
Q4 2019 Jan 17, 2020	BUY	$53.13 - $71.19 $13,282 - $17,797	250 New	250 $15,000
Q3 2019 Oct 09, 2019	SELL	$57.11 - $73.3 $14,277 - $18,325	-250 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$54.41 - $71.7 $13,602 - $17,925	250 New	250 $16,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.97B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.